BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

380 related articles for article (PubMed ID: 24830703)

  • 1. Colitis-associated neoplasia: molecular basis and clinical translation.
    Foersch S; Neurath MF
    Cell Mol Life Sci; 2014 Sep; 71(18):3523-35. PubMed ID: 24830703
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Colitis and colorectal cancer.
    Foersch S; Waldner MJ; Neurath MF
    Dig Dis; 2012; 30(5):469-76. PubMed ID: 23108302
    [TBL] [Abstract][Full Text] [Related]  

  • 3. From Inflammation to Cancer in Inflammatory Bowel Disease: Molecular Perspectives.
    Romano M; DE Francesco F; Zarantonello L; Ruffolo C; Ferraro GA; Zanus G; Giordano A; Bassi N; Cillo U
    Anticancer Res; 2016 Apr; 36(4):1447-60. PubMed ID: 27069120
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Possible Molecular Mechanisms by which Vitamin D Prevents Inflammatory Bowel Disease and Colitis-associated Colorectal Cancer.
    Luan Z; Ma Y; Xin Y; Qian J; Wang H
    Curr Med Chem; 2017; 24(9):911-917. PubMed ID: 27915990
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Chronic inflammatory bowel disease and cancer.
    Pohl C; Hombach A; Kruis W
    Hepatogastroenterology; 2000; 47(31):57-70. PubMed ID: 10690586
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inflammatory bowel disease and carcinogenesis.
    Nagao-Kitamoto H; Kitamoto S; Kamada N
    Cancer Metastasis Rev; 2022 Jun; 41(2):301-316. PubMed ID: 35416564
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Microbiome and colorectal cancer: Unraveling host-microbiota interactions in colitis-associated colorectal cancer development.
    Kang M; Martin A
    Semin Immunol; 2017 Aug; 32():3-13. PubMed ID: 28465070
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Microscopic features of colorectal neoplasia in inflammatory bowel diseases.
    Bressenot A; Cahn V; Danese S; Peyrin-Biroulet L
    World J Gastroenterol; 2014 Mar; 20(12):3164-72. PubMed ID: 24696602
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cancer in inflammatory bowel disease.
    Xie J; Itzkowitz SH
    World J Gastroenterol; 2008 Jan; 14(3):378-89. PubMed ID: 18200660
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Distinct clinicohistologic features of inflammatory bowel disease-associated colorectal adenocarcinoma: in comparison with sporadic microsatellite-stable and Lynch syndrome-related colorectal adenocarcinoma.
    Liu X; Goldblum JR; Zhao Z; Landau M; Heald B; Pai R; Lin J
    Am J Surg Pathol; 2012 Aug; 36(8):1228-33. PubMed ID: 22790862
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identification of Novel Core Genes Involved in Malignant Transformation of Inflamed Colon Tissue Using a Computational Biology Approach and Verification in Murine Models.
    Markov AV; Savin IA; Zenkova MA; Sen'kova AV
    Int J Mol Sci; 2023 Feb; 24(5):. PubMed ID: 36901742
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Malignant transformation in inflammatory bowel disease - surveillance guide.
    Stallmach A; Bielecki C; Schmidt C
    Dig Dis; 2009; 27(4):584-90. PubMed ID: 19897979
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Chemoprevention of Colitis-Associated Dysplasia or Cancer in Inflammatory Bowel Disease.
    Hsiao SW; Yen HH; Chen YY
    Gut Liver; 2022 Nov; 16(6):840-848. PubMed ID: 35670121
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Colorectal cancer and inflammatory bowel disease: epidemiology, risk factors, mechanisms of carcinogenesis and prevention strategies.
    Triantafillidis JK; Nasioulas G; Kosmidis PA
    Anticancer Res; 2009 Jul; 29(7):2727-37. PubMed ID: 19596953
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Endoscopy/surveillance in inflammatory bowel disease.
    Ahmadi AA; Polyak S
    Surg Clin North Am; 2007 Jun; 87(3):743-62. PubMed ID: 17560423
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cancer prevention in inflammatory bowel disease and the chemoprophylactic potential of 5-aminosalicylic acid.
    Bernstein CN; Eaden J; Steinhart AH; Munkholm P; Gordon PH
    Inflamm Bowel Dis; 2002 Sep; 8(5):356-61. PubMed ID: 12479651
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Alterations in p53, Microsatellite Stability and Lack of MUC5AC Expression as Molecular Features of Colorectal Carcinoma Associated with Inflammatory Bowel Disease.
    Gené M; Cuatrecasas M; Amat I; Veiga JA; Fernández Aceñero MJ; Fusté Chimisana V; Tarragona J; Jurado I; Fernández-Victoria R; Martínez Ciarpaglini C; Alenda González C; Zac C; Ortega de la Obra P; Fernández-Figueras MT; Esteller M; Musulen E
    Int J Mol Sci; 2023 May; 24(10):. PubMed ID: 37240002
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Colorectal Cancer in Inflammatory Bowel Disease: Mechanisms and Management.
    Shah SC; Itzkowitz SH
    Gastroenterology; 2022 Mar; 162(3):715-730.e3. PubMed ID: 34757143
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Genomic characterization of colitis-associated colorectal cancer.
    Kameyama H; Nagahashi M; Shimada Y; Tajima Y; Ichikawa H; Nakano M; Sakata J; Kobayashi T; Narayanan S; Takabe K; Wakai T
    World J Surg Oncol; 2018 Jul; 16(1):121. PubMed ID: 29966533
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Vitexin prevents colitis-associated carcinogenesis in mice through regulating macrophage polarization.
    Chen Y; Wang B; Yuan X; Lu Y; Hu J; Gao J; Lin J; Liang J; Hou S; Chen S
    Phytomedicine; 2021 Mar; 83():153489. PubMed ID: 33571919
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.